๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB ยท Real-Time Price ยท USD
1.190
+0.050 (4.39%)
At close: Nov 20, 2026, 4:00 PM EST
1.160
-0.030 (-2.52%)
After-hours: Nov 20, 2026, 4:50 PM EST

Chemomab Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-11.16-9.57-14.74-25.46-28.53-12.37
Net Income
-10.87-9-13.95-24.22-27.65-12.48
Earnings Per Share
-1.36-1.41-3.11-8.25-9.72-4.81
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.6510.3714.2719.7839.8961.16
Total Debt
--0.320.390.210.34
Net Cash (Debt)
4.6510.3713.9419.3939.6860.82
Net Cash Growth
-53.73%-25.65%-28.10%-51.13%-34.76%439.64%
Net Cash Per Share
0.581.633.116.6013.9523.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--11.13-15.39-23.61-20.37-12.37
Capital Expenditures
--0--0-0.07-0.24
Free Cash Flow
--11.13-15.39-23.61-20.44-12.61
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.